Abstract
During the last two decades, engineered nanomaterial/nanoparticles have emerged in different fields of our daily life. In fact they are used for a variety of applications, such as colour pigments, solar cells, and waste water treatment. Furthermore, nanoparticles are found in consumer products that may be in contact with the human organism, e.g., food packaging, shampoos, sunscreens, toothpastes, and cigarettes. Thus, it is of great importance to evaluate how nanoparticles interact both with human beings and with the environment, considering that nanoparticles are assimilated as waste in the environment and introduced in the food chain.
In assessing nanoparticle safety, their possible effects on immune responses are a major issue, since the immune system is deputed to defending and maintaining the integrity of the body, and its failure is the cause of damage and disease.
This brief review will focus on the effects of nanoparticles on immunity, with a special focus on human health, but also include immunity of environmental species (such as marine and earth invertebrates) as a key tool in predicting environmental nanosafety.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agashe HB, Dutta T, Garg M et al (2006) Investigations on the toxicological profile of functionalized fifth-generation poly (propylene-imine) dendrimer. J Pharm Pharmacol 58:1491–1498
Aggarwal P, Hall JB, McLeland CB et al (2009) Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61:428–437
Andreev SM, Babakhin AA, Petrukhina AO et al (2000) Immunogenic and allergenic properties of fullerene conjugates with amino acids and proteins. Dokl Biochem 370:4–7
Barmo C, Ciacci C, Canonico B et al (2013) In vivo effects of n-TiO2 on digestive gland and immune function of the marine bivalve Mytilus galloprovincialis. Aquat Toxicol 9:132–133
Bartneck M, Keul HA, Zwadlo-Klarwasser G et al (2010) Phagocytosis independent extracellular nanoparticle clearance by human immune cells. Nano Lett 10:59–63
Boraschi D, Costantino L, Italiani P (2012) Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. Nanomedicine (Lond) 7:121–131
Braden BC, Goldbaum FA, Chen BX et al (2000) X-ray crystal structure of an anti-Buckminsterfullerene antibody fab fragment: biomolecular recognition of C(60). Proc Natl Acad Sci U S A 97:12193–12197
Canesi L, Ciacci C, Fabbri R et al (2012) Bivalve molluscs as a unique target group for nanoparticle toxicity. Mar Environ Res 76:16–21
Caron W, Rawal S, Song G et al (2012) Bidirectional interaction between nanoparticles and cells of the mononuclear phagocyte system. In: Yarmush ML, Shi D (eds) Frontiers in nanobiomedical research. World Scientific Publishing, Singapore
Casals E, Pfaller T, Duschl A et al (2010) Time evolution of the nanoparticle protein corona. ACS Nano 4:3623–3632
Cassel SL, Eisenbarth SC, Iyer SS et al (2008) The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A 105:9035–9040
Champion JA, Mitragotri S (2006) Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A 103:4930–4934
Champion JA, Katare YK, Mitragotri S (2007) Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J Control Release 121:3–9
Chanan-Khan A, Szebeni J, Savay S et al (2003) Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Ann Oncol 14:1430–1437
Chang ZL (2009) Recent development of the mononuclear phagocyte system: in memory of Metchnikoff and Ehrlich on the 100th anniversary of the 1908 Nobel Prize in Physiology or Medicine. Biol Cell 101:709–721
Chen BX, Wilson SR, Das M et al (1998) Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics. Proc Natl Acad Sci U S A 95:10809–10813
Chen Z, Meng H, Xing G et al (2008) Age-related differences in pulmonary and cardiovascular responses to SiO2 nanoparticle inhalation: nanotoxicity has susceptible population. Environ Sci Technol 42:8985–8992
Chong CS, Cao M, Wong WW et al (2005) Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. J Control Release 102:85–99
Ciacci C, Canonico B, Bilanicova D et al (2012) Immunomodulation by different types of N-oxides in the hemocytes of the marine bivalve Mytilus galloprovincialis. PLoS One 7:e36937
Cooper EL (2010) Evolution of immune systems from self/not self to danger to artificial immune systems (AIS). Phys Life Rev 7:55–78
Csaba N, Sanchez A, Alonso MJ (2006) PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery. J Control Release 113:164–172
Cui Z, Mumper RJ (2002) Coating of cationized protein on engineered nanoparticles results in enhanced immune responses. Int J Pharm 238:229–239
Cui Z, Patel J, Tuzova M et al (2004) Strong T cell type-1 immune responses to HIV-1 Tat (1–72) protein-coated nanoparticles. Vaccine 22:2631–2640
Cui Z, Han SJ, Vangasseri DP et al (2005) Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier. Mol Pharm 2:22–28
Cukalevski R, Lundqvist M, Oslakovic C et al (2011) Structural changes in apolipoproteins bound to nanoparticles. Langmuir 27:14360–14369
Cuna M, Alonso-Sandel M, Remunan-Lopez C et al (2006) Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery. J Nanosci Nanotechnol 6:2887–2895
Demento SL, Eisenbarth SC, Foellmer HG et al (2009) Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 27:3013–3021
Demoy M, Andreux JP, Weingarten C et al (1999) In vitro evaluation of nanoparticles spleen capture. Life Sci 64:1329–1337
Deng ZJ, Liang M, Toth I et al (2012) Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses. Nanotoxicology 7:314–322
Dobrovolskaia MA, McNeil SE (2007) Immunological properties of engineered nanomaterials. Nat Nanotechnol 2:469–478
Dobrovolskaia MA, McNeil SE (2013) Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. J Control Release 172:456–466
Dobrovolskaia MA, Aggarwal P, Hall JB et al (2008) Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5:487–495
Dobrovolskaia MA, Germolec DR, Weaver J (2009) Evaluation of nanoparticle immunotoxicity. Nat Nanotechnol 4:411–414
Dobrovolskaia MA, Neun BW, Clogston JD et al (2013) Choice of method for endotoxin detection depends on nanoformulation. Nanomedicine (Lond) 9(12):1847–56. [Epub ahead of print]
Dostert C, Pétrilli V, Van Bruggen R et al (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674–677
Eisenbarth SC, Colegio OR, O’Connor W et al (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453:1122–1126
El Solh AA, Ramadan H (2006) Overview of respiratory failure in older adults. J Intensive Care Med 21:345–351
El-Temsah YS, Joner EJ (2012) Ecotoxicological effects on earthworms of fresh and aged nanosized zero-valent iron (nZVI) in soil. Chemosphere 89:76–82
Esmaeili F, Ghahremani MH, Esmaeili B et al (2008) PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. Int J Pharm 349:249–255
Fang C, Shi B, Pei YY et al (2006) In vivo tumor targeting of tumor necrosis factor alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur J Pharm Sci 27:27–36
Ferrari M (2008) Nanogeometry: beyond drug delivery. Nat Nanotechnol 3:131–132
Fleischer CC, Payne CK (2012) Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes. J Phys Chem B 116:8901–8907
Foged C, Brodin B, Frokjaer S et al (2005) Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 298:315–322
Gaucher G, Asahina K, Wang J et al (2009) Effect of poly(N-vinyl-pyrrolidone)-block-poly(D, L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles. Biomacromolecules 10:408–416
Goppert TM, Muller RH (2005) Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). Eur J Pharm Biopharm 60:361–372
Hall JB, Dobrovolskaia MA, Patri AK et al (2007) Characterization of nanoparticles for therapeutics. Nanomedicine 2:789–803
Hamad I, Hunter AC, Rutt KJ et al (2008) Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover. Mol Immunol 45:3797–3803
Hamilton RF Jr, Buford M, Xiang C et al (2012) NLRP3 inflammasome activation in murine alveolar macrophages and related lung pathology is associated with MWCNT nickel contamination. Inhal Toxicol 24:995–1008
Hirahara K, Poholek A, Vahedi G et al (2013) Mechanisms underlying helper T cell plasticity: implications for immune-mediated disease. J Allergy Clin Immunol 131:1276–1287
Hornung V, Bauernfeind F, Halle A et al (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9:847–856
Ishida T, Wang X, Shimizu T et al (2007) PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner. J Control Release 122:349–355
Judge A, McClintock K, Phelps JR et al (2006) Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes. Mol Ther 13:328–337
Kagan VE, Konduru NV, Feng W et al (2010) Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat Nanotechnol 5:354–359
Kettiger H, Schipanski A, Wick P et al (2013) Engineered nanomaterial uptake and tissue distribution: from cell to organism. Int J Nanomedicine 8:3255–3269
Kim TH, Nah JW, Cho MH et al (2006) Receptor-mediated gene delivery into antigen presenting cells using mannosylated chitosan/DNA nanoparticles. J Nanosci Nanotechnol 6:2796–2803
Koide H, Asai T, Hatanaka K et al (2010) T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes. Int J Pharm 392:218–223
Kotchey GP, Hasan SA, Kaparlov AA et al (2012) A natural vanishing act: the enzyme-catalyzed degradation of carbon nanomaterials. Acc Chem Res 45:1770–1781
Kreuter J (1995) Nanoparticles as adjuvants for vaccines. Pharm Biotechnol 6:463–472
Kvell K, Cooper EL, Engelmann P et al (2007) Blurring borders: innate immunity with adaptive features. Clin Dev Immunol 2007:83671
Latz E, Xiao TS, Stutz A (2013) Activation and regulation of the inflammasomes. Nat Rev Immunol 13:397–411
Lee SC, Parthasarathy R, Botwin K et al (2004) Biochemical and immunological properties of cytokines conjugated to dendritic polymers. Biomed Microdevices 6:191–202
Li LZ, Zhou DM, Peijnenburg WJ et al (2011) Toxicity of zinc oxide nanoparticles in the earthworm, Eisenia fetida and subcellular fractionation of Zn. Environ Int 37:1098–1104
Li R, Wang X, Ji Z et al (2013) Surface charge and cellular processing of covalently functionalized multiwall carbon nanotubes determine pulmonary toxicity. ACS Nano 7:2352–2368
Lieder R, Petersen PH, Sigurjónsson OE (2013) Endotoxins—the invisible companion in biomaterials research. Tissue Eng Part B Rev 19:391–402
Ling WL, Biro A, Bally I et al (2011) Proteins of the innate immune system crystallize on carbon nanotubes but are not activated. ACS Nano 5:730–737
Lunov O, Syrovets T, Loos C et al (2011) Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano 5:1657–1669
Lutsiak ME, Kwon GS, Samuel J (2006) Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses. J Pharm Pharmacol 58:739–747
Mahon E, Salvati A, Baldelli Bombelli F et al (2012) Designing the nanoparticle-biomolecule interface for “targeting and therapeutic delivery”. J Control Release 161:164–174
Manolova V, Flace A, Bauer M et al (2008) Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 38:1404–1413
Marsh EK, May RC (2012) Caenorhabditis elegans, a model organism for investigating immunity. Appl Environ Microbiol 78:2075–2081
Martinon F, Pétrilli V, Mayor A et al (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241
Masalova OV, Shepelev AV, Atanadze SN et al (1999) Immunostimulating effect of water-soluble fullerene derivatives—perspective adjuvants for a new generation of vaccine. Dokl Akad Nauk 369:411–413
Meng H, Yang S, Li Z et al (2011) Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. ACS Nano 5:4434–4447
Mitchell LA, Gao J, Wal RV et al (2007) Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol Sci 100:203–214
Mitchell LA, Lauer FT, Burchiel SW et al (2009) Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nat Nanotechnol 4:451–456
Moghimi SM, Andersen AJ, Ahmadvand D et al (2011) Material properties in complement activation. Adv Drug Deliv Rev 63:1000–1007
Mohamed BM, Verma NK, Davies AM et al (2012) Citrullination of proteins: a common post-translational modification pathway induced by different nanoparticles in vitro and in vivo. Nanomedicine (Lond) 7:1181–1195
Monopoli MP, Pitek AS, Lynch I et al (2013) Formation and characterization of the nanoparticle-protein corona. Methods Mol Biol 1025:137–155
Mottram PL, Leong D, Crimeen-Irwin B et al (2007) Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Mol Pharm 4:73–84
Moyano DF, Goldsmith M, Solfiell DJ et al (2012) Nanoparticle hydrophobicity dictates immune response. J Am Chem Soc 134:3965–3967
Muller RH, Maassen S, Weyhers H et al (1996) Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J Drug Target 4:161–170
Murphy KM (ed) (2011) Janeway’s immunobiology, 8th edn. Garland Science, New York
Nakayamada S, Takahashi H, Kanno Y et al (2012) Helper T cell diversity and plasticity. Curr Opin Immunol 24:297–302
Oostingh GJ, Casals E, Italiani P et al (2011) Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects. Part Fibre Toxicol 8:8
Paciotti GF, Myer L, Weinreich D et al (2004) Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 11:169–183
Palomäki J, Välimäki E, Sund J et al (2011) Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 5:6861–6870
Papayannopoulos V, Zychlinsky A (2009) NETs: a new strategy for using old weapons. Trends Immunol 30:513–521
Peer D (2012) Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles. Adv Drug Deliv Rev 64:1738–1748
Pulskamp K, Diabate S, Krug HF (2007) Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 168:58–74
Rajananthanan P, Attard GS, Sheikh NA et al (1999) Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses. Vaccine 17:715–730
Reddy ST, van der Vlies AJ, Simeoni E et al (2007) Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 25:1159–1164
Redhead HM, Davis SS, Illum L (2001) Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J Control Release 70:353–363
Rettig L, Haen SP, Bittermann AG et al (2010) Particle size and activation threshold: a new dimension of danger signaling. Blood 115:4533–4541
Roberts JC, Bhalgat MK, Zera RT (1996) Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J Biomed Mater Res 30:53–65
Roser M, Fischer D, Kissel T (1998) Surface-modified biodegradable albumin nano and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm 46:255–263
Salvador-Morales C, Flahaut E, Sim E et al (2006) Complement activation and protein adsorption by carbon nanotubes. Mol Immunol 43:193–201
Seok J, Warren HS, Cuenca AG et al (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 110:3507
Sharma A, Muresanu DF, Patnail R et al (2013) Size- and age-dependent neurotoxicity of engineered metal nanoparticles in rats. Mol Neurobiol 48:386–396
Smulders S, Kaiser JP, Zuin S et al (2012) Contamination of nanoparticles by endotoxin: evaluation of different test methods. Part Fibre Toxicol 9:41
Söderäll K (2010) Invertebrate immunity. Advances in experimental medicine and biology. Landes Bioscience and Springer Science + Business Media, LCC, New York, p 314
Stern ST, McNeil SE (2008) Nanotechnology safety concerns revisited. Toxicol Sci 101:4–21
Szebeni J, Alving CR, Rosivall L et al (2007) Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles. J Liposome Res 17:107–117
Tan Y, Li S, Pitt BR et al (1999) The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum Gene Ther 10:2153–2161
Thiele L, Rothen-Rutishauser B, Jilek S et al (2001) Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? J Control Release 76:59–71
Tomii A, Masugi F (1991) Production of anti-platelet-activating factor antibodies by the use of colloidal gold as carrier. Jpn J Med Sci Biol 44:75–80
Unrine JM, Hunyadi SE, Tsyusko OV et al (2010) Evidence for bioavailability of Au nanoparticles from soil and biodistribution within earthworms (Eisenia fetida). Environ Sci Technol 44:830813
van Zijverden M, Granum B (2000) Adjuvant activity of particulate pollutants in different mouse models. Toxicology 152:69–77
Vetten MA, Yah CS, Singh T et al (2014) Challenges facing sterilization and depyrogenation of nanoparticles: effects on structural stability and biomedical applications. Nanomedicine 10(7):1391–1399
Wang X, Ishida T, Kiwada H (2007) Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. J Control Release 119:236–244
Whitfield Aslund ML, McShane H, Simpson MJ et al (2012) Earthworm sublethal responses to titanium dioxide nanomaterial in soil detected by (1)H NMR metabolomics. Environ Sci Technol 46:1111–1118
Xiang SD, Scholzen A, Minigo G et al (2006) Pathogen recognition and development of particulate vaccines: does size matter? Methods 40:1–9
Xiang SD, Fuchsberger M, Karlson TDL et al (2012) Nanoparticles, immune modulation and vaccine delivery. In: Yarmush ML, Shi D (eds) Frontiers in nanobiomedical research. World Scientific Publishing, Singapore
Yazdi AS, Guarda G, Riteau N et al (2010) Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc Natl Acad Sci U S A 107:19449–19454
Zahr AS, Davis CA, Pishko MV (2006) Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir 22:8178–8185
Acknowledgements
This work was supported by the EU FP7 grant HUMUNITY (PITN-GA-2012-316383) and by the grant 2011–2114 of Fondazione Cariplo, Milano, Italy.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Wien
About this chapter
Cite this chapter
Italiani, P., Boraschi, D. (2016). Engineered Nanoparticles and the Immune System: Interaction and Consequences. In: Esser, C. (eds) Environmental Influences on the Immune System. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1890-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1890-0_9
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1888-7
Online ISBN: 978-3-7091-1890-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)